Arbutus Biopharma Corporation (ABUS)
Total Valuation
ABUS has a market cap or net worth of $419.24 million. The enterprise value is $286.97 million.
| Market Cap | 419.24M |
| Enterprise Value | 286.97M |
Important Dates
The last earnings date was Tuesday, November 7, 2023, before market open.
| Earnings Date | Nov 7, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
ABUS has 167.70 million shares outstanding. The number of shares has increased by 10.94% in one year.
| Shares Outstanding | 167.70M |
| Shares Change (YoY) | +10.94% |
| Shares Change (QoQ) | +0.87% |
| Owned by Insiders (%) | 24.84% |
| Owned by Institutions (%) | 43.41% |
| Float | 104.51M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 18.85 |
| Forward PS | 22.61 |
| PB Ratio | 3.51 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 12.90 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.34, with a Debt / Equity ratio of 0.02.
| Current Ratio | 6.34 |
| Quick Ratio | 6.11 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -103.24 |
Financial Efficiency
Return on equity (ROE) is -56.40% and return on invested capital (ROIC) is -64.72%.
| Return on Equity (ROE) | -56.40% |
| Return on Assets (ROA) | -41.80% |
| Return on Capital (ROIC) | -64.72% |
| Revenue Per Employee | $231,677 |
| Profits Per Employee | -$786,135 |
| Employee Count | 96 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +7.76% in the last 52 weeks. The beta is 1.90, so ABUS's price volatility has been higher than the market average.
| Beta (1Y) | 1.90 |
| 52-Week Price Change | +7.76% |
| 50-Day Moving Average | 1.98 |
| 200-Day Moving Average | 2.27 |
| Relative Strength Index (RSI) | 77.41 |
| Average Volume (30 Days) | 663,316 |
Short Selling Information
The latest short interest is 6.19 million, so 3.69% of the outstanding shares have been sold short.
| Short Interest | 6.19M |
| Short Previous Month | 6.18M |
| Short % of Shares Out | 3.69% |
| Short % of Float | 5.93% |
| Short Ratio (days to cover) | 7.80 |
Income Statement
In the last 12 months, ABUS had revenue of $22.24 million and -$75.47 million in losses. Loss per share was -$0.46.
| Revenue | 22.24M |
| Gross Profit | 22.24M |
| Operating Income | -78.47M |
| Pretax Income | -75.47M |
| Net Income | -75.47M |
| EBITDA | -73.39M |
| EBIT | -74.75M |
| Loss Per Share | -$0.46 |
Balance Sheet
The company has $134.18 million in cash and $1.91 million in debt, giving a net cash position of $132.27 million or $0.79 per share.
| Cash & Cash Equivalents | 134.18M |
| Total Debt | 1.91M |
| Net Cash | 132.27M |
| Net Cash Per Share | $0.79 |
| Equity / Book Value | 119.34M |
| Book Value Per Share | 0.71 |
| Working Capital | 119.28M |
Cash Flow
In the last 12 months, operating cash flow was -$85.63 million and capital expenditures -$1.14 million, giving a free cash flow of -$86.78 million.
| Operating Cash Flow | -85.63M |
| Capital Expenditures | -1.14M |
| Free Cash Flow | -86.78M |
| FCF Per Share | -$0.52 |
Margins
Gross margin is 100.00%, with operating and profit margins of -352.80% and -339.32%.
| Gross Margin | 100.00% |
| Operating Margin | -352.80% |
| Pretax Margin | -339.32% |
| Profit Margin | -339.32% |
| EBITDA Margin | -329.99% |
| EBIT Margin | -336.07% |
| FCF Margin | -390.16% |
Dividends & Yields
ABUS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -18.00% |
| FCF Yield | -20.70% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.94% |
| Shareholder Yield | -10.94% |
Analyst Forecast
The average price target for ABUS is $6.00, which is 140.00% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.00 |
| Price Target Difference | 140.00% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (5Y) | 7.03% |
| EPS Growth Forecast (5Y) | -17.77% |
Stock Splits
The last stock split was on November 4, 2010. It was a reverse split with a ratio of 1:5.
| Last Split Date | Nov 4, 2010 |
| Split Type | Reverse |
| Split Ratio | 1:5 |
Scores
ABUS has an Altman Z-Score of -5.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.21 |
| Piotroski F-Score | 2 |